Skip to main content
S&P 5007,683.11+1.51%DOW53,335.29+2.99%NASDAQ25,714.14+1.35%BTC$80,010.00+2.84%ETH$2,411.88+5.33%GOLD$4,071.00+3.31%OIL$88.69-7.70%
Smart Investors Daily
SID Premium
Merck KGaA logo

OTC · MKKGY

Merck KGaA

Healthcare · Drug Manufacturers - Specialty & Generic

$33.96

Up+$0.75 (+2.26%)

Updated Nov 4, 2026, 6:57 PM

SID Score

7.9/10

Composite research score

Smart Money

46/100

Neutral

Market cap
61.14B
P/E ratio
17.39
Dividend yield
1.47%
52-week range
$23.73 – $34.19
Volume
51.2K
Avg. volume
155.75K

Price performance · MKKGY

MKKGY price history

1M range · 13 trading sessions · Daily adjusted prices

Prices through Oct 22, 2026

MKKGY closed at $32.91 after 13 trading sessions, up 5.32% for the selected period.

Last close
$32.91
Period change
+5.32%
Period low
$30.78
Period high
$33.09
Daily close
View OHLC price history
MKKGY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 22, 2026$32.85$33.10$32.82$32.908551.2K
Oct 21, 2026$32.67$32.741$32.10$32.229118.99K
Oct 20, 2026$32.67$33.12$32.66$33.09140.38K
Oct 19, 2026$32.11$32.56$32.07$32.2785.51K
Oct 16, 2026$32.50$32.53$32.24$32.27120.54K
Oct 15, 2026$32.20$32.202$32.01$32.0755.14K
Oct 14, 2026$31.29$31.67$31.29$31.6282.07K
Oct 13, 2026$31.57$31.57$30.84$30.885110.57K
Oct 12, 2026$31.12$31.12$30.91$30.9970.07K
Oct 9, 2026$30.90$31.11$30.87$31.06138.22K
Oct 8, 2026$30.91$30.92$30.39$30.78117.27K
Oct 7, 2026$31.32$31.496$30.99$31.3771.28K
Oct 6, 2026$31.93$31.93$31.10$31.246186.86K

Latest MKKGY news

The latest Smart Investors Daily articles mentioning MKKGY.

Stock researchCompany · Overview

MKKGY research

Overview

Company profile and research snapshot.

Company profile

MERCK KGAA SPNS/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$53.96
Implied upside
—
Analysts
11
MKKGY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNBuy—
Sep 21, 2026DAY BY DAYHold—
Sep 10, 2026BAADER EUROPE / ALPHAVALUEBuy—
Sep 4, 2026EQUITA SIMHold—
Sep 3, 2026JEFFERIESHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 29, 2026

MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea

MilliporeSigma Announces the Opening of €300 Million Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea Merck KGaA, Darmstadt, Germany’s Asia-Pacific Bioprocessing Production Center Opening Ceremony Burlington, Massachusetts, Oct. 29, 2026 (GLOBE NEWSWIRE) -- The company’s largest life science investment in Asia-Pacific to date expands regional manufacturing capacityIntegrated digital systems support automated data capture and end-to-end batch traceabilityAdvances the company’s

Yahoo · Oct 27, 2026

ProtaGene Appoints Former Merck KGaA CDMO Leader Matthias Bucerius as Chief Executive Officer

Matthias Bucerius, PhD CEO, ProtaGene HEIDELBERG, Germany, and BOSTON, Massachusetts, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ProtaGene, a leading global contract research organization (CRO) specializing in advanced analytics for biologics and cell and gene therapies, today announced the appointment of Matthias Bucerius, PhD, as Chief Executive Officer, effective immediately. For drug developers, analytical data often sits on the critical path from IND (Investigational New Drug) and IMPD (Investigatio

Yahoo · Oct 22, 2026

Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis

The global peptide synthesis market is projected to grow from $0.98 billion in 2026 to $1.54 billion by 2031, a new report finds, as GLP-1 drugs and expanding peptide pipelines drive demand for custom synthesis; Thermo Fisher, Merck KGaA, GenScript and Bachem are among 30 companies profiled.Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Peptide Synthesis Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. The global peptide synthesis market is projected to grow from

Yahoo · Oct 21, 2026

Global Bioprocessing Reagent Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, Danaher, Merck KGaA and Sartorius Accelerate AI and Single-Use Systems

Boost ROI via single-use systems, AI optimization and continuous processing to cut capital costs, contamination and downtime while improving yield, scalability and efficiency.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Reagent Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioprocessing reagent market is experiencing rapid expansion, driven by rising biologics production, increased vaccine manufacturing, and continued investment in pharmaceutical

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By